Finance

Lists
ROSSARI:NSE
Rossari Biotech Ltd
425,00 ₹
+1,69%
(+7,05) 1D
1 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ROSSARI...
Open
419,35 ₹
High
434,90 ₹
Low
413,10 ₹
Mkt. cap
23,54 млрд
Avg. vol.
78,13 мың
Volume
65,35 мың
Dividend
0,12%
Quarterly dividend
0,13 ₹
Ex-dividend date
2026 ж. 10 шіл.
P/E ratio
15,63
52-wk high
690,30 ₹
52-wk low
375,00 ₹
EPS
27,20 ₹
No. of employees
585
Open
419,35 ₹
High
434,90 ₹
Low
413,10 ₹
Mkt. cap
23,54 млрд
Avg. vol.
78,13 мың
Volume
65,35 мың
Dividend
0,12%
Quarterly dividend
0,13 ₹
Ex-dividend date
2026 ж. 10 шіл.
P/E ratio
15,63
52-wk high
690,30 ₹
52-wk low
375,00 ₹
EPS
27,20 ₹
No. of employees
585
News stories
From web sources and news partners
Profile
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries. The company was started in 2003 as a partnership firm titled Rossari Labtech and was incorporated into a company in 2009 and was renamed as Rossari Biotech. It has two R&D facilities, one at Silvassa manufacturing facility and the second in Dahej. Wikipedia
About Rossari Biotech Ltd
CEO-
Employees585
Founded2009 ж. 10 там.
Headquarters-
SectorSpeciality chemicals
Last report
2026 ж. 20 шіл.
Fiscal period
Q1 2027
EPS / Est. (INR)
6,33 ₹ / 8,80 ₹
-28,07%miss
Revenue / Est. (INR)
6,97 млрд / 6,71 млрд
+3,87%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
5,86 млрд
5,82 млрд
6,85 млрд
6,97 млрд
Cost of goods sold
4,01 млрд
4,01 млрд
5,04 млрд
4,91 млрд
Cost of revenue
4,01 млрд
4,01 млрд
5,04 млрд
4,91 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
377,99 млн
402,56 млн
463,26 млн
440,44 млн
Operating expense
1,32 млрд
1,32 млрд
1,44 млрд
1,51 млрд
Total operating expenses
5,32 млрд
5,32 млрд
6,48 млрд
6,42 млрд
Operating income
536,91 млн
492,59 млн
369,04 млн
550,05 млн
Other non operating income
16,04 млн
5,09 млн
-27,71 млн
31,87 млн
EBT including unusual items
496,72 млн
425,01 млн
642,43 млн
476,72 млн
EBT excluding unusual items
496,72 млн
425,01 млн
437,87 млн
476,72 млн
Income tax expense
127,96 млн
97,27 млн
182,76 млн
125,77 млн
Effective tax rate
25,76%
22,89%
28,45%
26,38%
Other operating expenses
755,29 млн
717,50 млн
736,59 млн
817,11 млн
Net income
368,76 млн
327,74 млн
459,67 млн
350,95 млн
Net profit margin
6,29%
5,63%
6,71%
5,03%
Earnings per share
6,65
5,91
8,29
6,33
Interest and investment income
-
-
13,51 млн
-
Interest expense
-60,91 млн
-76,65 млн
-90,59 млн
-109,77 млн
Net interest expenses
-60,91 млн
-76,65 млн
-77,08 млн
-109,77 млн
Depreciation and amortization charges
182,33 млн
196,14 млн
235,28 млн
256,15 млн
EBITDA
716,82 млн
645,98 млн
544,80 млн
725,80 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары